| P50 | author | Amogh P Belagodu | Q87591090 |
| P2093 | author name string | Roberto Galvez | |
| | Liridon Zendeli | |
| | Bernard J Slater | |
| P2860 | cites work | VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex | Q24293027 |
| | Localization of FMRP-associated mRNA granules and requirement of microtubules for activity-dependent trafficking in hippocampal neurons | Q28266983 |
| | Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome | Q28273791 |
| | Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins | Q28574559 |
| | Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo | Q28577046 |
| | The mGluR theory of fragile X mental retardation | Q29615060 |
| | Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 |
| | Spaced training rescues memory and ERK1/2 signaling in fragile X syndrome model mice | Q30603928 |
| | Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells | Q33553437 |
| | Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome | Q33775794 |
| | Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus | Q34189802 |
| | Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome | Q34200046 |
| | Learned spatiotemporal sequence recognition and prediction in primary visual cortex | Q34204184 |
| | Molecular mechanisms of fragile X syndrome: a twenty-year perspective | Q34226308 |
| | mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3 | Q34231591 |
| | Visual experience induces long-term potentiation in the primary visual cortex | Q34806975 |
| | Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway | Q35058837 |
| | Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome | Q35871033 |
| | Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain | Q36116089 |
| | Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice | Q36342394 |
| | Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis | Q36850573 |
| | Dysregulation of mTOR signaling in fragile X syndrome | Q36879282 |
| | The fragile X continuum: new advances and perspectives | Q37150380 |
| | Reduced activity-dependent protein levels in a mouse model of the fragile X premutation. | Q37663611 |
| | The synapsins: key actors of synapse function and plasticity. | Q37741320 |
| | Stimulus-selective response plasticity in the visual cortex: an assay for the assessment of pathophysiology and treatment of cognitive impairment associated with psychiatric disorders | Q37948404 |
| | A cholinergic mechanism for reward timing within primary visual cortex. | Q41132106 |
| | Absence of expression of the FMR-1 gene in fragile X syndrome | Q41669091 |
| | Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. | Q43601730 |
| | Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency. | Q43892381 |
| | Dendritic spine and dendritic field characteristics of layer V pyramidal neurons in the visual cortex of fragile-X knockout mice. | Q44124708 |
| | Targeting the endocannabinoid system in the treatment of fragile X syndrome. | Q44430989 |
| | NMDA receptor-dependent ocular dominance plasticity in adult visual cortex | Q44485260 |
| | TSC2 regulates VEGF through mTOR-dependent and -independent pathways | Q44574474 |
| | Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex | Q45041368 |
| | The Drosophila fragile X gene negatively regulates neuronal elaboration and synaptic differentiation | Q47071801 |
| | Neocortical vasculature abnormalities in the Fragile X mental retardation syndrome | Q47384203 |
| | Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures | Q48203803 |
| | Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation | Q48315567 |
| | Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome | Q48337615 |
| | Fragile X syndrome and cerebral perfusion abnormalities: single-photon emission computed tomographic study | Q48343584 |
| | Enhanced perfusion in eyes and cerebral perfusion defects in a patient with Fragile X Syndrome | Q48403183 |
| | Instructive effect of visual experience in mouse visual cortex | Q48458118 |
| | Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines. | Q48599377 |
| | Reward timing in the primary visual cortex | Q48615149 |
| | Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome. | Q51930328 |
| | Transgenic mouse model for the fragile X syndrome. | Q52200260 |
| | Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor | Q73310317 |
| | Vascular endothelial growth factor rescues HN33 neural cells from death induced by serum withdrawal | Q74307907 |
| | Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system | Q78003462 |
| P433 | issue | 1 | |
| P921 | main subject | fragile X syndrome | Q221472 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 14-25 | |
| P577 | publication date | 2016-06-10 | |
| P1433 | published in | Developmental Neurobiology | Q15716734 |
| P1476 | title | Blocking elevated VEGF-A attenuates non-vasculature Fragile X syndrome abnormalities | |
| P478 | volume | 77 | |